ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01166542
Recruitment Status : Completed
First Posted : July 21, 2010
Last Update Posted : November 5, 2014
Sponsor:
Information provided by (Responsible Party):
Oncolytics Biotech

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2012
  Actual Study Completion Date : May 2014